<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02060240</url>
  </required_header>
  <id_info>
    <org_study_id>OHSUIRB#10299</org_study_id>
    <secondary_id>5KL2TR000152-08</secondary_id>
    <nct_id>NCT02060240</nct_id>
  </id_info>
  <brief_title>Physical Activity and Obesity</brief_title>
  <official_title>Physical Activity and Obesity: The Role of Nitric Oxide and Eicosanoids in Regulating Capillary Perfusion and Vascular Insulin Resistance</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oregon Health and Science University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Oregon Health and Science University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to see if a twelve-week exercise intervention in overweight or
      obese subjects with pre-diabetes or early disease course type 2 diabetes can lead to improved
      skeletal muscle capillary blood flow by improving substances that dilate blood vessels and
      result in improved insulin sensitivity.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>February 2014</start_date>
  <completion_date type="Anticipated">April 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Insulin mediated skeletal muslce blood flow and capillary recruitment</measure>
    <time_frame>3 months</time_frame>
    <description>Contrast enhanced ultrasound skeltal muscle perfusion imaging will be performed at rest and during glucose steady state infusion during an insulin clamp. The change in blood flow will be determined between the resting state and at peak steady state to determine the absolute increase in skeletal muslce blood flow (ml/min/g) as well as the absolute increase in capillary blood volume (ml/g) of tissue</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quantification of endothelial derived Vasodilators</measure>
    <time_frame>3 months</time_frame>
    <description>To quantify the changes in endothelial derived vasodilators. For this aim nitric oxide bioavailability as tested by flow mediated vasodilation will be performed and reported as absolute change (cm) and percent change (%) in brachial artery diameter from baseline to post ischemic occlusion of the forearm. Plasma samples for eicosanoids will be collected and assessed by liquid chormatography/mass spectroscopy to to assess changes in endothelial derived vasodilators.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Correalte changes in fitness to vasodilators, blood flow, and insulin sensitivity</measure>
    <time_frame>3 months</time_frame>
    <description>Aim 3. To correlate changes in fitness as measured by peak VO2 and anaerobic threshold during cardiopulmonary exercise testing with changes in endothelial derived vasodilators, skeletal muscle blood flow, and insulin sensitivity.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Obesity</condition>
  <condition>Prediabetic State</condition>
  <condition>Sedentary Lifestyle</condition>
  <arm_group>
    <arm_group_label>High Activity Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subject randomized to High Activity group will have 36, one hour training sessions over 12 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard of Care Group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>The standard of care group will maintain their baseline level of activity for 12 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>High Activity</intervention_name>
    <description>The high activity group will undergo a 12 week ramped exercise protocol.</description>
    <arm_group_label>High Activity Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Males and females ages 30-60 years of age

          2. Overweight and Obese (28&lt; BMI &lt;45)

          3. Confirmed pre-diabetic (5.7≤ HbA1c &lt; 6.5)

          4. Type 2 DM, Diagnosis 2 years or less, on no medications or metformin only, HbA1c ≤ 6.7

        Exclusion Criteria:

          1. Stage 3 chronic kidney disease (glomerular filtration rate [GFR] &lt; 60)

          2. Obstructive Coronary artery disease

          3. Congestive heart failure (ejection fraction &lt; 55%)

          4. Peripheral vascular disease,

          5. Degenerative joint disease, musculoskeletal disease, or peripheral vascular disease
             that limits ability to exercise

          6. Know hypersensitivity to Definity® ultrasound contrast agent

          7. Intra-cardiac or pulmonary shunt

          8. The use of antithrombotic agents or a severe bleeding diathesis due to risk of
             bleeding with intravenous and arterial line placement

          9. Physical activity greater than three hours per week

         10. Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Scott M Chadderdon, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Oregon Health and Science University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Scott M Chadderdon, MD</last_name>
    <phone>503-494-8750</phone>
    <email>chadderd@ohsu.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Kara Helgren</last_name>
    <phone>503-346-3539</phone>
    <email>helgren@ohsu.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Oregon Health &amp; Science University</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97239</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Scott M Chadderdon, MD</last_name>
      <phone>503-494-8750</phone>
      <email>chadderd@ohsu.edu</email>
    </contact>
    <investigator>
      <last_name>Scott M Chadderdon, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.ohsu.edu/research/rda/so/knight_viewstudy.php?id=IRB00010299&amp;WT_rank=1</url>
    <description>Physical Activity and Obesity Trial Information</description>
  </link>
  <reference>
    <citation>Chadderdon SM, Belcik JT, Smith E, Pranger L, Kievit P, Grove KL, Lindner JR. Activity restriction, impaired capillary function, and the development of insulin resistance in lean primates. Am J Physiol Endocrinol Metab. 2012 Sep 1;303(5):E607-13. doi: 10.1152/ajpendo.00231.2012. Epub 2012 Jun 26.</citation>
    <PMID>22739105</PMID>
  </reference>
  <reference>
    <citation>Coggins M, Lindner J, Rattigan S, Jahn L, Fasy E, Kaul S, Barrett E. Physiologic hyperinsulinemia enhances human skeletal muscle perfusion by capillary recruitment. Diabetes. 2001 Dec;50(12):2682-90.</citation>
    <PMID>11723050</PMID>
  </reference>
  <reference>
    <citation>Clerk LH, Vincent MA, Jahn LA, Liu Z, Lindner JR, Barrett EJ. Obesity blunts insulin-mediated microvascular recruitment in human forearm muscle. Diabetes. 2006 May;55(5):1436-42.</citation>
    <PMID>16644702</PMID>
  </reference>
  <verification_date>April 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 6, 2014</study_first_submitted>
  <study_first_submitted_qc>February 7, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 12, 2014</study_first_posted>
  <last_update_submitted>April 20, 2015</last_update_submitted>
  <last_update_submitted_qc>April 20, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 22, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Oregon Health and Science University</investigator_affiliation>
    <investigator_full_name>Scott M. Chadderdon</investigator_full_name>
    <investigator_title>Assistant Professor Cardiovascular Medicine</investigator_title>
  </responsible_party>
  <keyword>Obesity</keyword>
  <keyword>Prediabetic State</keyword>
  <keyword>Sedentary Lifestyle</keyword>
  <keyword>Insulin Resistance</keyword>
  <keyword>Endothelium</keyword>
  <keyword>Eicosanoids</keyword>
  <keyword>Nitric Oxide</keyword>
  <keyword>Regional Blood Flow</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity</mesh_term>
    <mesh_term>Insulin Resistance</mesh_term>
    <mesh_term>Prediabetic State</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nitric Oxide</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

